Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
2
×
europe
2
×
europe blog main
europe top stories
fda
life sciences
national blog main
abbvie
alkermes
allergan
boehringer ingelheim
boston blog main
boston top stories
buprenorphine
cariprazine
empagliflozin
felipe jain
indiana blog main
indiana top stories
jess fiedorowicz
jessica jeffrey
karim calis
lumateperone
m health fairview
marc goodman
massachusetts general hospital
national institutes of health (nih)
national top stories
new york blog main
new york top stories
olanzapine
opioid
ottawa hospital
samidorphan
slgt2 inhibitor
steven meisel
svb leerink
type 1 diabetes
What
drug
fda
alkermes
antipsychotic
approval
benefits
bid
boehringer
caveats
commonly
designed
diabetes
effect
eli
expand
fallen
favor
gain
ingelheim
lilly
marketed
medicine
medicine’s
offer
panel
patients
prescribed
psyche
rejects
short
treatment
type
vote
weighs
weight
won
Language
unset
Current search:
europe
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes